Including whole-genome sequencing into clinical genomic testing found cancer-driving mutations other sequencing methods failed to identify.
The funding will support CPIC, which provides guidelines to help clinicians understand how genetic test results should be used to optimize drug therapy.
World Health Organization, St. Jude Children’s Research Hospital collaborate against childhood cancer
New global childhood cancer effort aims to cure at least 60 percent of children with six of the most common kinds of cancer worldwide by 2030.
St. Jude scientists have discovered a link between sepsis during cancer treatment and long-term neurocognitive dysfunction.
Evidence suggests liquid phase separation, a process that explains why oil and water separate, may contribute to cancer, including prostate cancer.
The research will aid basic understanding of brain development, and also help understanding cellular origins of brain disorders caused by errors in development.
Geneticists discovered that mTORC3 aids cancers' resistance to rapamycin and related drugs, offering the promise of new drug therapies to treat cancers.
Read the latest on the roots of mixed phenotype acute leukemia (MPAL), including how the findings might affect treatment of patients with the high-risk cancer.
Flu infections pose a significant risk to infants. Read about the T cells the immune system relies on to repair lung damage in infants infected with influenza.
Read about what happened when researchers looked beyond mutations to understand the developmental origins and vulnerabilities of rhabdomyosarcoma.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.